Occlude Defect ,
To provide global doctors and patients with safe and innovate medical devices to treat cardiovascular diseases
Being an innovative company, we consistently explore new idea and methods
On March 26, 2018, the government of Guangdong Province announced LifeTech Scientific (Shenzhen) Co., Ltd. as the winner of the first prize of the Guangdong Science and Technology Award
On March 28, 2018 in Hong Kong, LifeTech, a leading supplier of minimally invasive cardiovascular interventional devices announced its audited overall results for the year ended December 31, 2017.
China Interventional Therapeutics (CIT) 2018 was held at the Suzhou Jinji Lake International Convention Center from March 22 to 25, 2018. LifeTech was invited to the academic event and showed the participants a number of innovative highlights.
LifeTech Scientific (Shenzhen) Co., Ltd. as the winner of the first prize of the Guangdong Science and Technology Award for 2017
LifeTech Scientific Corporation has entered into a strategic partnership with Ally Bridge Group (“ABG”).
Lifetech Scientific (Shenzhen) Co. Ltd is pleased to announce that its HeartTone implantable cardiac pacemaker has been approved by the China Food and Drug Administration (CFDA).
Lifetech is a leading developer, manufacturer and vendor of advanced minimally invasive medical devices for cardiovascular and peripheral vascular diseases and disorders.
Founded in 1999, we are now the second largest provider of congenital heart defect occluders in the world and the largest provider to BRIC countries.